iCIMS Technology Awarded Patent by the United States Patent and Trademark Office

iCIMS is pleased to announce that it has been granted a US patent for the technology underlying its award-winning software platform LATTICE.

This comes on the heels of iCIMS being announced as the inaugural winner of the Medical Software Industry Association (MSIA) Best Innovation by a Member Company 2019. See article here.

iCIMS won the award for its implementation of a LATTICE powered solution for the Sydney Adventist Hospital’s Cancer Centre of Excellence that enabled automation of the various multidisciplinary team meetings that form part of the core offering in the San’s fight against cancer.

The power of the LATTICE technology was demonstrated with a seamless move to remote team collaboration due to the CoVid-19 crisis. Ali Besiso, iCIMS’ Managing Director was pleased with the result, “For one of our major clients to be able to bring a new tumour stream online, and do it remotely, during this crisis shows the power of our infrastructure and its unique way of very quickly building and deploying clinical systems, a uniqueness that has been acknowledged by the recent granting of a Patent for our technology by the United States Patent and Trade Mark Office.”

Melbourne Health Breast Cancer Services moves to Phase II/HL7

Melbourne Health Breast Cancer Service Phase II/HL7

The Melbourne Health Breast Cancer Service RUTH II system has moved to Phase II of the implementation with the successful addition of the HL7 module.  The module enables integration to the hospitals’ Patient Administration Systems (PAS).

A key advantage of the extra functionality is the ability to process HL7 A40 merge messages to update each patient’s medical record number to the new Parkville Precinct Unique Record Number (PURN) shared across all three hospitals (including the Peter MacCallum Cancer Centre where the joint weekly Multi-Disciplinary Team Meetings take place).

The integration, coupled with iCIMS’ workflow engine, reduces cognitive load, lowers ‘click fatigue’ and increases accuracy by pre-filling form entries from the PAS and from patient clinical details held within RUTH II. This functionality reduces the time taken by staff to enter data and prepare for Multidisciplinary Team Meetings. Figures from usage data indicate that the RUTH II system has saved over 20% of interns’ data entry time.  Time that is now available to work directly with patients.

Melbourne Health Breast Cancer goes live with RUTH II from iCIMS

Melbourne Health – Breast Cancer Service

Melbourne Health has upgraded its Clinical & Research information management system used by the shared Breast Cancer service of The Royal Melbourne and The Royal Women’s Hospitals. The new system, installed by Innovative Clinical Information Management Systems (iCIMS) is also designed to allow easy access from other institutions within the Parkville precinct.

The iCIMS system (RUTH II) is a full Clinical Information System (CIS) which enables the two hospitals to track the patient journey, manage the Multidisciplinary Team Meetings and transparently share patient information.

iCIMS RUTH II for Royal Melbourne Hospital

iCIMS used its advanced technology to enable a concept it calls Immediate Adaptability to very quickly prototype a system tailored specifically to the needs, workflows and outcomes required by the two hospitals.

One facet of Immediate Adaptability that sets iCIMS developed systems apart is the speed of user-driven system design changes. This speed, in turn, allows iCIMS to deploy a unique installation model; once the initial handover is completed, the client has three months to request system design changes without additional cost.  The result is a highly tailored, fit for purpose solution that has overwhelmingly high user buy-in from senior clinicians, nurses, data administration and ancillary services.

Professor Bruce Mann –   Director of Breast Tumour Stream, Victorian Comprehensive Cancer Centre (VCCC) has seen the effects of iCIMS’ Immediate Adaptability within his team; the MDM team has been very impressed that changes suggested during the MDM one week had been implemented and operational the following week.

As an example of the immediacy of changes, with the RUTH II system, there were 98 design changes requested by the clinical users as a result of them using the system in a live environment in the first three months. Of those changes, 93 have been delivered already with an average turnaround time of 3 days without any system downtime.

As well as the core functionality, the system has additional modules that produce:

  • End of treatment summaries and outcomes
  • A survivorship component
  • Breast audit data exports

RUTH II has been designed to be fully expandable into other tumour streams and other sites within the Parkville precinct and is already remotely accessible from the Peter MacCallum Cancer Centre (PMCC).